Digital Health Market – Global Forecast To 2030
디지털 헬스 시장 – 제공 내용(하드웨어(웨어러블, 임플란트), 앱(원격 의료(RPM), DTx, 환자 포털, 약국), 질환(당뇨병, CVS, 정신건강), 유스 케이스(치료, 모니터링, 재활 및 회복), 최종 사용자, 지역별 – 2030년까지의 세계 예측
Digital Health Market by Offering (Hardware(Wearables, Implants), Apps (Telehealth (RPM), DTx, Patient Portals, Pharmacy)), Disease (Diabetes, CVS, Mental Health), Use Case (Treatment, Monitoring, Rehab & Recovery), End User, and Region – Global Forecast to 2030
| 조사회사 | MarketsandMarkets |
| 출판년월 | 2025년9월 |
| 페이지 수 | 452 |
| 도표 수 | 534 |
| 라이센스 | Single User License |
| 가격 | USD 4,950 |
| 구성 | 영문조사보고서 |
본 보고서는 디지털 헬스 시장을 분석하고, 제품, 질병, 사용 사례, 최종 사용자 및 지역을 기준으로 다양한 시장 부문의 시장 규모와 미래 성장 잠재력을 예측하는 것을 목표로 합니다. 또한, 이 시장에서 활동하는 주요 업체에 대한 경쟁 분석과 함께 회사 프로필, 제품 제공, 최근 동향 및 주요 시장 전략을 제공합니다.
이 보고서는 기존 기업뿐만 아니라 신규 진입 기업/소규모 기업도 시장의 흐름을 파악하는 데 도움이 될 것이며, 이를 통해 시장 점유율을 확대하는 데 도움이 될 것입니다. 이 보고서를 구매하는 기업은 다음 전략 중 하나 또는 여러 가지를 조합하여 시장에서의 입지를 강화할 수 있습니다.
세계 디지털 헬스 시장은 2025년 1,991억 달러에서 2030년 5,735억 달러로 성장할 것으로 예상되며, 예측 기간 동안 23.6%의 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 가치 기반 의료 수요 증가, 만성 질환 부담 증가, 그리고 예방 의료에 대한 중요성 증대에 힘입어 이 시장은 꾸준히 성장하고 있습니다. 인구 고령화와 의료비 증가로 인해 의료 서비스 제공자와 보험사는 의료 자원 활용을 최적화하는 동시에 치료 결과를 개선하기 위해 디지털 도구에 주목하고 있습니다. 원격 환자 모니터링, 디지털 치료법, 모바일 건강 앱과 같은 솔루션은 특히 당뇨병, 고혈압, 심장병과 같은 만성 질환에 대한 지속적인 재택 치료를 가능하게 하는 데 중요한 역할을 하고 있습니다. 디지털 중재에 대한 보험 적용 범위 확대, 건강 추적에 대한 소비자의 높은 관심, 그리고 의료 기술 기업과 대형 기술 기업의 혁신은 이 시장을 더욱 뒷받침하고 있습니다. 이러한 성장세에도 불구하고, 이 분야는 지속적인 어려움에 직면해 있으며, 그중에서도 가장 큰 어려움은 데이터 보안 및 개인정보 보호에 대한 우려, 새로운 디지털 치료법에 대한 규제 불확실성, 그리고 노령층과 저소득층의 접근성을 제한하는 디지털 격차입니다. 확장 가능하고 공평하며 양질의 의료 서비스를 제공하는 디지털 헬스의 잠재력을 온전히 실현하기 위해서는 이러한 장벽을 반드시 해결해야 합니다.
The global digital health market is projected to reach USD 573.5 billion by 2030 from USD 199.1 billion in 2025, at a high CAGR of 23.6% during the forecast period. The market is advancing steadily, propelled by the increasing demand for value-based care, the rising burden of chronic diseases, and a growing emphasis on preventive healthcare. With aging populations and escalating healthcare costs, providers and payers are turning to digital tools to improve care outcomes while optimizing resource utilization.
Solutions such as remote patient monitoring, digital therapeutics, and mobile health apps are playing a critical role in enabling continuous, at-home care, especially for chronic conditions like diabetes, hypertension, and heart disease. The market is further supported by expanding insurance coverage for digital interventions, strong consumer interest in health tracking, and innovation from both medtech and big tech players. Despite this momentum, the sector faces persistent challenges, chief among them are concerns over data security and privacy, regulatory uncertainty for emerging digital therapeutics, and the digital divide that limits access for elderly and low-income populations. These barriers must be addressed to fully realize the potential of digital health in delivering scalable, equitable, and high-quality care.
“Mental & behavioral health under the disease segment is expected to register the fastest growth during the forecast period.”
In 2024, mental & behavioral health emerged as the fastest-growing segment of the digital health market. This is due to the rising awareness of mental well-being, increasing prevalence of stress, anxiety, and depression, and the reduced stigma around seeking help. The expansion of telepsychiatry, therapy apps, and AI-driven mental health platforms provides accessible, affordable, and confidential support, while integration with wearable devices and remote monitoring allows real-time tracking of behavioral patterns. These factors, combined with employer wellness programs and supportive healthcare policies, are driving rapid adoption and market expansion in this segment.
“The patients & consumers segment is projected to dominate the digital health market, by end user, during the forecast period.”
In 2024, patients & consumers was the fastest-growing end-user segment in the digital health market. This is because of increasing health awareness, rising smartphone and wearable adoption, and the demand for personalized, on-demand healthcare solutions. Digital health apps, telemedicine platforms, and remote monitoring tools empower individuals to actively manage their health, access care anytime, and track vital signs or lifestyle metrics in real time. The shift toward preventive care, convenience-focused healthcare delivery, and self-management of chronic conditions has made patients and consumers the most dynamic growth driver in the market.
“Asia Pacific to witness the highest growth rate during the forecast period.”
The Asia Pacific region is expected to register the fastest growth in the digital health market over the forecast period. Government initiatives promoting telemedicine, electronic health records, and AI-driven healthcare, combined with rising healthcare investments and expanding private sector participation, are accelerating adoption. Companies such as Halodoc (Indonesia) raised USD 100 million (in 2023), bringing its total to USD 258 million, with over 20 million monthly users on its platform. Government-led initiatives such as India’s Ayushman Bharat Digital Mission (ABDM) is building a national digital health infrastructure, spanning EHRs, citizen health IDs, and analytics. In addition, strong private sector participation, increasing venture capital investments, and strategic partnerships between technology companies and healthcare providers are fueling innovation.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The break-down of primary interviews is as mentioned below:
- By Company Type – Tier 1: 31%, Tier 2: 28%, and Tier 3: 41%
- By Designation – C-level: 31%, Director-level: 25%, and Others: 44%
- By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%
Key Players in the Digital Health Market
The key players operating in the digital health market include Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), Fitbit (US), Dexcom, Inc. (US), Boston Scientific Corporation (US), Masimo (US), Teladoc Health, Inc. (US), American Well (US), Hims & Hers Health, Inc. (US), Headspace (US), Noom, Inc. (US), Cerebral Inc. (US), Epic System Corporation (US), Omada Health Inc. (US), ORACLE (US), Click Therapeutics (US), Welldoc, Inc. (US), EverlyWell (US), TruDoc Healthcare LLC (UAE), CareSimple Inc. (US), VivaLNK, Inc. (US), Biobeat (Israel), and Virtual Therapeutics Corp. (US).
Research Coverage:
The report analyzes the digital health market and aims to estimate the market size and future growth potential of various market segments, based on offering, disease, use case, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.
This report provides insights into:
Analysis of key drivers (Increasing penetration of smartphones, tablets, and other mobile platforms, Rising geriatric population and subsequent increase in prevalence of chronic diseases, Rising focus on patient-centric healthcare solutions, Increase in the use of wearables, Advancements in Al, Sensors & Connectivity (5G and 6G), Growth of Al-Powered Virtual Assistants and Chatbots), restraints (Interoperability issues, Low Digital Literacy in Certain Demographics), opportunities (Shift toward intelligent health ecosystem to deliver personalized health experiences, Increasing shift towards outpatient care model, Improving regulatory support and reimbursements, Advancements in digital health), and challenges (Clinical Validation & Long-Term Efficacy, Data Privacy and security concerns) influencing the growth of the digital health market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital health market
- Market Development: Comprehensive information on the lucrative emerging markets, components, deployments, technologies, applications, end users, and regions
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the digital health market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players, like Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), and Apple Inc. (US), in the digital health market
Table of Contents
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 38
1.3.2 INCLUSIONS & EXCLUSIONS 39
1.3.3 YEARS CONSIDERED 40
1.3.4 CURRENCY CONSIDERED 40
1.4 STAKEHOLDERS 41
1.5 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
2.1.1 SECONDARY DATA 44
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 45
2.1.2.1 Key data from primary interviews 47
2.1.2.2 Insights from primary experts 47
2.1.2.3 Breakdown of primary sources 48
2.2 RESEARCH METHODOLOGY 48
2.3 MARKET SIZE ESTIMATION 49
2.4 DATA TRIANGULATION 58
2.5 MARKET RANKING ANALYSIS 59
2.6 RISK ASSESSMENT 59
2.7 STUDY ASSUMPTIONS 59
2.8 LIMITATIONS 60
2.8.1 METHODOLOGY-RELATED LIMITATIONS 60
2.8.2 SCOPE-RELATED LIMITATIONS 60
3 EXECUTIVE SUMMARY 61
4 PREMIUM INSIGHTS 66
4.1 DIGITAL HEALTH MARKET OVERVIEW 66
4.2 NORTH AMERICA: DIGITAL HEALTH MARKET, BY END USER AND COUNTRY 67
4.3 DIGITAL HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
4.4 DIGITAL HEALTH MARKET: REGIONAL MIX 69
4.5 DIGITAL HEALTH MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 69
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
5.2.1 DRIVERS 71
5.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms 71
5.2.1.2 Rising geriatric population and subsequent increase in prevalence of chronic diseases 71
5.2.1.3 Rising focus on patient-centric healthcare solutions 72
5.2.1.4 Rising use of wearables 73
5.2.1.5 Advancements in AI, sensors, and connectivity (5G and 6G) 73
5.2.1.6 Growth of AI-powered virtual assistants and chatbots 74
5.2.2 RESTRAINTS 74
5.2.2.1 Low digital literacy in certain demographics 74
5.2.2.2 Interoperability issues 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Shift toward intelligent health ecosystem to deliver personalized health experiences 75
5.2.3.2 Increasing shift towards outpatient care 76
5.2.3.3 Improving regulatory support and reimbursements 76
5.2.3.4 Advancements in digital health 77
5.2.4 CHALLENGES 77
5.2.4.1 Healthcare gap in emerging economies 77
5.2.4.2 Privacy and security concerns 78
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80
5.4 INDUSTRY TRENDS 80
5.4.1 EMERGENCE OF VALUE-BASED STRATEGY FOR CONTINUOUS CARE 80
5.4.2 HOME: NEW HEALTHCARE HUB 81
5.4.3 TECHNOLOGICALLY ENABLED PRIMARY CARE SERVICES 81
5.4.4 RISING AWARENESS OF DIGITAL THERAPEUTICS TO TREAT HUMAN DISEASES 81
5.4.5 SURGE IN MHEALTH APPS 81
5.5 ECOSYSTEM ANALYSIS 82
5.6 SUPPLY CHAIN ANALYSIS 84
5.7 TECHNOLOGY ANALYSIS 85
5.7.1 KEY TECHNOLOGIES 85
5.7.1.1 mHealth apps 85
5.7.1.2 Wearable sensors & devices 86
5.7.1.3 Remote patient monitoring 86
5.7.1.4 Digital therapeutics 87
5.7.1.5 Telehealth/virtual care platforms 87
5.7.1.6 AI-powered tools 88
5.7.2 COMPLEMENTARY TECHNOLOGIES 88
5.7.2.1 Cloud computing & edge processing 88
5.7.2.2 Data analytics & visualization 88
5.7.2.3 Bluetooth & IoT connectivity 89
5.7.2.4 EHR integration 89
5.7.3 ADJACENT TECHNOLOGIES 89
5.7.3.1 Digital twins 89
5.7.3.2 AR/VR & extended reality (XR) 90
5.7.3.3 Voice assistants/smart speakers 90
5.8 TARIFF AND REGULATORY ANALYSIS 91
5.8.1 TARIFF DATA FOR HS CODE 9018 91
5.8.2 TARIFF DATA FOR HS CODE 9021 92
5.8.3 TARIFF DATA FOR HS CODE 8517 93
5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.8.5 REGULATORY FRAMEWORK 102
5.9 PRICING ANALYSIS 104
5.9.1 INDICATIVE PRICE, BY OFFERING 105
5.9.2 INDICATIVE PRICE, BY REGION 106
5.10 PORTER’S FIVE FORCES ANALYSIS 106
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 107
5.10.2 BARGAINING POWER OF BUYERS 107
5.10.3 THREAT OF SUBSTITUTES 107
5.10.4 THREAT OF NEW ENTRANTS 108
5.10.5 BARGAINING POWER OF SUPPLIERS 108
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
5.11.2 BUYING CRITERIA 109
5.12 PATENT ANALYSIS 110
5.12.1 PATENT PUBLICATION TRENDS FOR DIGITAL HEALTH MARKET 110
5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL HEALTH 111
5.12.3 MAJOR PATENTS IN DIGITAL HEALTH MARKET 112
5.13 UNMET NEEDS AND END-USER EXPECTATIONS 113
5.13.1 UNMET NEEDS IN DIGITAL HEALTH MARKET 113
5.13.2 END-USER EXPECTATIONS 113
5.14 KEY CONFERENCES AND EVENTS 114
5.15 CASE STUDY ANALYSIS 115
5.15.1 CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA) 115
5.15.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM 116
5.15.3 CASE STUDY 3: APPLE & NHS TEAMS 116
5.16 DIGITAL HEALTH MARKET: INVESTMENT LANDSCAPE AND FUNDING SCENARIO 117
5.17 TRADE ANALYSIS 117
5.17.1 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 8518) 118
5.17.2 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9021) 119
5.17.3 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9022) 120
5.17.4 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9018) 121
5.18 DIGITAL HEALTH MARKET BUSINESS MODELS 122
5.18.1 SUBSCRIPTION-BASED MODELS 122
5.18.2 SOFTWARE AS A SERVICE (SAAS)/PLATFORM AS A SERVICE (PAAS) 122
5.18.3 FREEMIUM MODELS WITH TIERED ACCESS 122
5.18.4 OUTCOMES-BASED AND VALUE-BASED MODELS 122
5.19 IMPACT OF AI/GEN AI IN DIGITAL HEALTH MARKET 123
5.19.1 KEY USE CASES 124
5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 125
5.19.2.1 Artificial intelligence in public health 125
5.19.2.2 Artificial intelligence in digital health—issues and dimensions of ethical concerns 126
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 126
5.19.3.1 Telehealth and telemedicine 127
5.19.3.2 Wearable devices 127
5.19.3.3 Remote patient monitoring (RPM) 127
5.19.3.4 Mobile health (mHealth) 127
5.19.4 USER READINESS & IMPACT ASSESSMENT 127
5.19.4.1 User readiness 127
5.19.4.1.1 User A: Healthcare providers 127
5.19.4.1.2 User B: Healthcare payers 128
5.19.4.1.3 User C: Patients & consumers 128
5.19.4.1.4 User D: Pharmaceutical, biotech, and MedTech companies (including CROs) 128
5.19.4.1.5 User E: Other end users (academic institutes, research centers, government bodies) 128
5.19.4.2 Impact assessment 128
5.19.4.2.1 User A: Healthcare providers 128
5.19.4.2.1.1 Implementation 128
5.19.4.2.1.2 Impact 128
5.19.4.2.2 User B: Healthcare payers 129
5.19.4.2.2.1 Implementation 129
5.19.4.2.2.2 Impact 129
5.19.4.2.3 User C: Patients & consumers 129
5.19.4.2.3.1 Implementation 129
5.19.4.2.3.2 Impact 129
5.19.4.2.4 User D: Pharmaceutical, biotech, and MedTech companies (including CROs) 130
5.19.4.2.4.1 Implementation 130
5.19.4.2.4.2 Impact 130
5.19.4.2.5 User E: Other end users (academic institutes, research centers, government bodies) 130
5.19.4.2.5.1 Implementation 130
5.19.4.2.5.2 Impact 130
5.20 IMPACT OF 2025 US TARIFFS—DIGITAL HEALTH MARKET 131
5.20.1 INTRODUCTION 131
5.20.2 KEY TARIFF RATES 132
5.20.3 PRICE IMPACT ANALYSIS 132
5.20.4 IMPACT ON COUNTRIES/REGIONS 133
5.20.4.1 US 133
5.20.5 EUROPE 134
5.20.6 ASIA PACIFIC 134
5.20.7 IMPACT ON END-USE INDUSTRIES 135
5.20.7.1 Healthcare providers 135
5.20.7.2 Healthcare payers 135
5.20.7.3 Patients and consumers 135
5.20.7.4 Pharmaceutical, biotechnology, and MedTech companies 135
5.20.7.5 Other end users 136
5.21 REIMBURSEMENT ANALYSIS 136
5.22 RISK FACTORS AND MARKET ENTRY BARRIERS 139
5.23 FUTURE OUTLOOK AND DISRUPTION SCENARIOS 140
6 DIGITAL HEALTH MARKET, BY OFFERING 141
6.1 INTRODUCTION 142
6.2 HARDWARE 142
6.2.1 SMART HARDWARE SOLUTIONS VITAL IN POWERING DIGITAL HEALTH 142
6.2.2 WEARABLES 143
6.2.2.1 Wearables to empower patients with real-time health monitoring 143
6.2.3 CONSUMER-GRADED WEARABLE HEALTHCARE DEVICES 144
6.2.3.1 Wearable healthcare devices to empower consumers to be proactive about their well-being 144
6.2.4 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES 145
6.2.4.1 Clinical-grade devices to allow remote care with continuous monitoring 145
6.2.5 IMPLANTABLE DEVICES 146
6.2.5.1 Real-time data transmission to healthcare providers for proactive intervention and personalized care 146
6.2.6 HANDHELD & PORTABLE DEVICES 147
6.2.6.1 Compact design and integration with mobile health applications to make them highly effective for use in remote care 147
6.2.7 STATIONARY DEVICES 148
6.2.7.1 Stationary devices to be upgraded with IoT integration, AI-driven analytics, and cloud-enabled interoperability 148
6.3 SOLUTIONS/APPLICATIONS 148
6.3.1 TELEHEALTHCARE/TELEMEDICINE 150
6.3.1.1 Demand to advance connected care via virtual health platforms 150
6.3.2 REMOTE PATIENT MONITORING 150
6.3.2.1 Expected to be more seamlessly integrated with telemedicine platforms, expanding their capabilities 150
6.3.3 VIRTUAL CARE & VIDEO CONSULTATION 151
6.3.3.1 Offering enhanced efficiency, accessibility, and accuracy in remote healthcare, assisting in triaging patients and automating documentation 151
6.3.4 VIRTUAL SITTING & NURSING PLATFORMS 152
6.3.4.1 Offering remote patient monitoring with bidirectional communication 152
6.4 MHEALTH APPS 153
6.4.1 TRANSFORMING CARE DELIVERY WITH MOBILE HEALTH SOLUTIONS 153
6.5 DIGITAL THERAPEUTICS 154
6.5.1 EMPOWERING HEALTH BY COMBINING REAL-TIME DATA COLLECTION, PATIENT ENGAGEMENT TOOLS, AND INTEGRATION WITH HEALTHCARE PROVIDERS’ SYSTEMS 154
6.6 DIGITAL PHARMACY & MEDICATION ACCESS 155
6.6.1 ENHANCING MEDICATION ACCESS BY REACHING RURAL OR UNDERSERVED POPULATIONS, REDUCING TRAVEL AND WAIT TIMES, AND IMPROVING CONTINUITY OF CARE 155
6.7 DIGITAL DIAGNOSTICS & AT-HOME TESTING 156
6.7.1 MOSTLY USED IN GLUCOSE MONITORING AND OTHER INFECTIOUS DISEASE TESTS, CHOLESTEROL AND LIPID PANELS, GENETIC TESTING, AND HORMONE OR FERTILITY ASSESSMENTS 156
6.8 PATIENT PORTALS 157
6.8.1 PERSONALIZED HEALTH CONTENT, APPOINTMENT REMINDERS, AND SECURE MESSAGING AIM TO IMPROVE PATIENT ENGAGEMENT AND CARE COORDINATION 157
6.9 OTHER DIGITAL HEALTH SOLUTIONS/APPLICATIONS 158
7 DIGITAL HEALTH MARKET, BY DISEASE 160
7.1 INTRODUCTION 161
7.2 DIABETES 162
7.2.1 INTEGRATING AI IN DIGITAL HEALTH TO CATER TO DIABETIC PATIENTS 162
7.3 CARDIOLOGY 163
7.3.1 OFFERING EARLIER DETECTION, CONTINUOUS MONITORING, AND PERSONALIZED MANAGEMENT OF CARDIOVASCULAR CONDITIONS 163
7.4 MENTAL HEALTH & BEHAVIORAL HEALTH 164
7.4.1 IMPROVING ACCESSIBILITY TO MENTAL HEALTH SERVICES, ESPECIALLY IN UNDERSERVED REGIONS 164
7.5 RESPIRATORY DISORDERS 165
7.5.1 ENABLING REAL-TIME MONITORING OF LUNG FUNCTION, MEDICATION ADHERENCE, AND OXYGEN LEVELS 165
7.6 LIFESTYLE & WELLNESS IMPROVEMENT 166
7.6.1 EXPANDING ACCESS AND PERSONALIZING CARE IN MENTAL & BEHAVIORAL HEALTH THROUGH DIGITAL HEALTH 166
7.7 NEUROLOGY 166
7.7.1 ADVANCING NEUROLOGICAL CARE WITH DIGITAL HEALTH INNOVATIONS 166
7.8 MUSCULOSKELETAL DISORDERS/PAIN MANAGEMENT 167
7.8.1 ACCELERATING INNOVATION IN HANDHELD & PORTABLE DEVICES TO BOOST MARKET GROWTH 167
7.9 ONCOLOGY 168
7.9.1 ADOPTION OF AI IN REMOTE PATIENT MONITORING (RPM) TO LEAD TO ITS EMERGING AS PROMISING SOLUTION TO SUPPORT PERSONALIZED CARE 168
7.10 WOMEN’S HEALTH & REPRODUCTIVE HEALTH 169
7.10.1 ENHANCING PREVENTIVE CARE, EMPOWERING WOMEN WITH SELF-MANAGEMENT TOOLS, AND STRENGTHENING OUTCOMES IN REPRODUCTIVE AND MATERNAL HEALTH 169
7.11 OTHER DISEASES 170
8 DIGITAL HEALTH MARKET, BY USE CASE 171
8.1 INTRODUCTION 172
8.2 PREVENTIVE CARE & WELLNESS 172
8.2.1 DRIVING PROACTIVE HEALTH MANAGEMENT THROUGH DIGITAL INNOVATION 172
8.3 DIAGNOSIS 173
8.3.1 ADVANCING DIAGNOSIS THROUGH AI-POWERED SYMPTOM CHECKING
AND EARLY DETECTION 173
8.4 TREATMENT 174
8.4.1 FEEDING REAL-TIME DATA TO HEALTHCARE PROVIDERS, ALLOWING TREATMENT ADJUSTMENTS AND PROACTIVE INTERVENTIONS 174
8.5 PATIENT MONITORING 175
8.5.1 SHIFT TOWARD PERSONALIZED, SCALABLE, AND PREVENTIVE CARE 175
8.6 REHABILITATION & RECOVERY 176
8.6.1 PARTICULARLY IMPACTFUL IN POST-SURGICAL CARE, NEUROLOGICAL REHABILITATION, STROKE RECOVERY, AND MUSCULOSKELETAL THERAPY 176
8.7 OTHER USE CASES 177
9 DIGITAL HEALTH MARKET, BY END USER 179
9.1 INTRODUCTION 180
9.2 HEALTHCARE PROVIDERS 180
9.2.1 HOSPITALS 182
9.2.1.1 Rise in demand for high-quality care and government support to encourage digital health adoption in hospitals 182
9.2.2 CLINICS & OTHER OUTPATIENT SETTINGS 182
9.2.2.1 Increase in demand for cost-effective care and postoperative monitoring to drive digital health adoption in outpatient settings 182
9.2.3 OTHER HEALTHCARE PROVIDERS 183
9.3 HEALTHCARE PAYERS 184
9.3.1 PUBLIC PAYERS 185
9.3.1.1 Driving population health and value-based care through digital innovation 185
9.3.2 PRIVATE PAYERS 186
9.3.2.1 Personalized benefit designs, value-based provider contracting, and delivering consumer-centric experiences 186
9.4 PATIENTS & CONSUMERS 187
9.4.1 AI AND WEARABLE DEVICES TO DRIVE GROWTH IN DIGITAL HEALTH FOR PERSONALIZED CARE AND ACCESSIBILITY 187
9.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES 188
9.5.1 PHARMACEUTICAL AND BIOTECH ADOPTION OF DIGITAL HEALTH TO ENHANCE DRUG DEVELOPMENT, PATIENT ENGAGEMENT, AND ADHERENCE 188
9.6 OTHER END USERS 189
10 DIGITAL HEALTH MARKET, BY REGION 190
10.1 INTRODUCTION 191
10.2 NORTH AMERICA 192
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 192
10.2.2 US 198
10.2.2.1 Integration of AI, data interoperability, and virtual-first care models to drive market 198
10.2.3 CANADA 204
10.2.3.1 Advancing health equity and access through digital infrastructure 204
10.3 EUROPE 209
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 209
10.3.2 GERMANY 214
10.3.2.1 Innovation-focused policy framework and digital infrastructure expansion to support growth 214
10.3.3 UK 219
10.3.3.1 Increase in prevalence of chronic and lifestyle-related diseases and high penetration of wearables to drive market 219
10.3.4 FRANCE 224
10.3.4.1 Government support for e-Health to propel market 224
10.3.5 ITALY 229
10.3.5.1 Digital transformation and integrated care to support market growth 229
10.3.6 SPAIN 234
10.3.6.1 Health system modernization and data-driven care to enable digital health growth in Spain 234
10.3.7 REST OF EUROPE 239
10.4 ASIA PACIFIC 244
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 245
10.4.2 CHINA 251
10.4.2.1 High burden of chronic diseases to fuel market growth 251
10.4.3 JAPAN 256
10.4.3.1 Large geriatric population and strong push toward modernization to propel market 256
10.4.4 INDIA 261
10.4.4.1 Growing adoption of telemedicine and mounting pressure to reduce healthcare expenditure to drive market 261
10.4.5 AUSTRALIA 266
10.4.5.1 Telehealth and digital integration to drive growth in Australia’s digital health market 266
10.4.6 SOUTH KOREA 271
10.4.6.1 AI, data ecosystems, and cross-sector synergy to power South Korea’s digital health growth 271
10.4.7 REST OF ASIA PACIFIC 276
10.5 LATIN AMERICA 281
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 281
10.5.2 BRAZIL 286
10.5.2.1 Government digitalization push and interoperability frameworks to catalyze market expansion 286
10.5.3 MEXICO 291
10.5.3.1 Government reforms, infrastructural expansion, and chronic disease burden to drive market 291
10.5.4 REST OF LATIN AMERICA 296
10.6 MIDDLE EAST & AFRICA 301
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302
10.6.2 GCC 307
10.6.2.1 AI leadership, virtual infrastructure, and policy alignment to power digital health growth in GCC 307
10.6.2.2 Saudi Arabia 312
10.6.2.2.1 Rapid digital health transformation to propel market in Saudi Arabia 312
10.6.2.3 UAE 317
10.6.2.3.1 UAE emerges as regional pioneer in digital healthcare innovation 317
10.6.2.4 Rest of GCC 322
10.6.3 SOUTH AFRICA 327
10.6.3.1 Infrastructure expansion, youthful demographics, and innovation ecosystems to accelerate digital health growth 327
10.6.4 REST OF MIDDLE EAST & AFRICA 332
11 COMPETITIVE LANDSCAPE 337
11.1 INTRODUCTION 337
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 337
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL
HEALTH MARKET 337
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 339
11.4 MARKET SHARE ANALYSIS, 2024 340
11.5 BRAND/SOFTWARE COMPARISON 343
11.6 COMPANY VALUATION & FINANCIAL METRICS 344
11.6.1 FINANCIAL METRICS 344
11.6.2 COMPANY VALUATION 345
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 345
11.7.1 STARS 345
11.7.2 EMERGING LEADERS 345
11.7.3 PERVASIVE PLAYERS 346
11.7.4 PARTICIPANTS 346
11.7.5 COMPANY FOOTPRINT 347
11.7.6 REGION FOOTPRINT 348
11.7.7 OFFERING FOOTPRINT 349
11.7.8 DISEASE FOOTPRINT 350
11.7.9 USE CASE FOOTPRINT 351
11.7.10 END USER FOOTPRINT 352
11.8 STARTUP/SME EVALUATION MATRIX, 2024 353
11.8.1 PROGRESSIVE COMPANIES 353
11.8.2 DYNAMIC COMPANIES 353
11.8.3 RESPONSIVE COMPANIES 353
11.8.4 STARTING BLOCKS 353
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 355
11.8.5.1 Detailed list of key startups/SMEs 355
11.8.5.2 Competitive benchmarking of startups/SMEs 355
11.9 COMPETITIVE SCENARIO AND TRENDS 356
11.9.1 PRODUCT LAUNCHES & APPROVALS 356
11.9.2 DEALS 357
11.9.3 OTHER DEVELOPMENTS 358
12 COMPANY PROFILES 359
12.1 KEY PLAYERS 359
12.1.1 MEDTRONIC 359
12.1.1.1 Business overview 359
12.1.1.2 Products offered 360
12.1.1.3 Recent developments 362
12.1.1.3.1 Product launches & approvals 362
12.1.1.3.2 Deals 363
12.1.1.3.3 Other developments 364
12.1.1.4 MnM view 364
12.1.1.4.1 Key strengths 364
12.1.1.4.2 Strategic choices 364
12.1.1.4.3 Weaknesses and competitive threats 365
12.1.2 ABBOTT 366
12.1.2.1 Business overview 366
12.1.2.2 Products offered 367
12.1.2.3 Recent developments 368
12.1.2.3.1 Product launches & approvals 368
12.1.2.3.2 Deals 369
12.1.2.4 MnM view 369
12.1.2.4.1 Key strengths 369
12.1.2.4.2 Strategic choices 370
12.1.2.4.3 Weaknesses and competitive threats 370
12.1.3 DEXCOM, INC. 371
12.1.3.1 Business overview 371
12.1.3.2 Products offered 372
12.1.3.3 Recent developments 372
12.1.3.3.1 Product launches & approvals 372
12.1.3.3.2 Deals 373
12.1.3.4 MnM view 374
12.1.3.4.1 Key strengths 374
12.1.3.4.2 Strategic choices 374
12.1.3.4.3 Weaknesses and competitive threats 374
12.1.4 KONINKLIJKE PHILIPS N.V. 375
12.1.4.1 Business overview 375
12.1.4.2 Products offered 376
12.1.4.3 Recent developments 378
12.1.4.3.1 Product launches & approvals 378
12.1.4.3.2 Deals 378
12.1.4.3.3 Expansions 379
12.1.4.4 MnM view 379
12.1.4.4.1 Key strengths 379
12.1.4.4.2 Strategic choices 379
12.1.4.4.3 Weaknesses and competitive threats 379
12.1.5 FITBIT, INC. (GOOGLE) 380
12.1.5.1 Business overview 380
12.1.5.2 Products offered 381
12.1.5.3 Recent developments 382
12.1.5.3.1 Product launches & approvals 382
12.1.5.3.2 Deals 382
12.1.5.4 MnM view 383
12.1.5.4.1 Key strengths 383
12.1.5.4.2 Strategic choices 383
12.1.5.4.3 Weaknesses and competitive threats 383
12.1.6 OMRON HEALTHCARE, INC. 384
12.1.6.1 Business overview 384
12.1.6.2 Products offered 385
12.1.6.3 Recent developments 387
12.1.6.3.1 Product launches & approvals 387
12.1.6.3.2 Deals 387
12.1.7 APPLE, INC. 389
12.1.7.1 Business overview 389
12.1.7.2 Products offered 390
12.1.7.3 Recent developments 391
12.1.7.3.1 Product launches & approvals 391
12.1.7.3.2 Deals 392
12.1.8 BOSTON SCIENTIFIC CORPORATION 393
12.1.8.1 Business overview 393
12.1.8.2 Products offered 394
12.1.8.3 Recent developments 395
12.1.8.3.1 Product launches & approvals 395
12.1.8.3.2 Deals 396
12.1.9 MASIMO 397
12.1.9.1 Business overview 397
12.1.9.2 Products offered 398
12.1.9.3 Recent developments 399
12.1.9.3.1 Product launches & approvals 399
12.1.9.3.2 Deals 400
12.1.10 TELADOC HEALTH, INC. 401
12.1.10.1 Business overview 401
12.1.10.2 Products offered 402
12.1.10.3 Recent developments 403
12.1.10.3.1 Product launches & approvals 403
12.1.10.3.2 Deals 404
12.1.11 AMERICAN WELL 406
12.1.11.1 Business overview 406
12.1.11.2 Products offered 407
12.1.11.3 Recent developments 408
12.1.11.3.1 Product launches & approvals 408
12.1.11.3.2 Deals 408
12.1.11.3.3 Other developments 409
12.1.12 HIMS & HERS HEALTH, INC. 410
12.1.12.1 Business overview 410
12.1.12.2 Products offered 411
12.1.12.3 Recent developments 412
12.1.12.3.1 Product launches & approvals 412
12.1.12.3.2 Deals 413
12.1.13 HEADSPACE 414
12.1.13.1 Business overview 414
12.1.13.2 Products offered 414
12.1.13.3 Recent developments 415
12.1.13.3.1 Product launches & approvals 415
12.1.13.3.2 Deals 416
12.1.14 NOOM, INC. 417
12.1.14.1 Business overview 417
12.1.14.2 Products offered 417
12.1.14.3 Recent developments 418
12.1.14.3.1 Product launches & approvals 418
12.1.14.3.2 Deals 418
12.1.15 CEREBRAL INC. 420
12.1.15.1 Business overview 420
12.1.15.2 Products offered 420
12.1.15.3 Recent developments 421
12.1.15.3.1 Product launches & approvals 421
12.1.15.3.2 Deals 421
12.1.16 EPIC SYSTEMS CORPORATION 423
12.1.16.1 Business overview 423
12.1.16.2 Products offered 423
12.1.16.3 Recent developments 424
12.1.16.3.1 Product launches & approvals 424
12.1.16.3.2 Deals 424
12.1.17 OMADA HEALTH INC. 425
12.1.17.1 Business overview 425
12.1.17.2 Products offered 426
12.1.17.3 Recent developments 427
12.1.17.3.1 Product launches & approvals 427
12.1.17.3.2 Deals 428
12.1.18 ORACLE 429
12.1.18.1 Business overview 429
12.1.18.2 Products offered 430
12.1.18.3 Recent developments 431
12.1.18.3.1 Product launches & approvals 431
12.1.18.3.2 Deals 431
12.1.19 CLICK THERAPEUTICS, INC. 432
12.1.19.1 Business overview 432
12.1.19.2 Products offered 432
12.1.19.3 Recent developments 433
12.1.19.3.1 Product launches & approvals 433
12.1.19.3.2 Deals 434
12.1.20 WELLDOC, INC. 435
12.1.20.1 Business overview 435
12.1.20.2 Products offered 435
12.1.20.3 Recent developments 436
12.1.20.3.1 Product launches & approvals 436
12.1.20.3.2 Deals 436
12.1.21 EVERLYWELL 437
12.1.21.1 Business overview 437
12.1.21.2 Products offered 437
12.1.21.3 Recent developments 438
12.1.21.3.1 Product launches & approvals 438
12.1.21.3.2 Deals 439
12.2 OTHER PLAYERS 440
12.2.1 TRUDOC HEALTHCARE LLC 440
12.2.2 CARESIMPLE INC. 441
12.2.3 VIVALNK, INC. 441
12.2.4 BIOBEAT 442
12.2.5 VIRTUAL THERAPEUTICS CORP. 442
13 APPENDIX 443
13.1 DISCUSSION GUIDE 443
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 448
13.3 CUSTOMIZATION OPTIONS 450
13.4 RELATED REPORTS 450
13.5 AUTHOR DETAILS 451
LIST OF TABLES
TABLE 1 FACTOR ANALYSIS 55
TABLE 2 LARGEST HEALTHCARE DATA BREACHES (2021–2025) 78
TABLE 3 AVERAGE TARIFFS UNDER HS CODE 9018 91
TABLE 4 AVERAGE TARIFFS UNDER HS CODE 9021 92
TABLE 5 AVERAGE TARIFFS UNDER HS CODE 8517 93
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 98
TABLE 9 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
TABLE 10 DIGITAL HEALTH MARKET: REGULATORY STANDARDS 101
TABLE 11 REGULATORY REQUIREMENTS IN NORTH AMERICA 102
TABLE 12 REGULATORY REQUIREMENTS IN EUROPE 103
TABLE 13 REGULATORY REQUIREMENTS IN ASIA PACIFIC 103
TABLE 14 REGULATORY REQUIREMENTS IN LATIN AMERICA 104
TABLE 15 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 104
TABLE 16 INDICATIVE PRICE OF DIGITAL HEALTH SOLUTIONS, BY OFFERING, 2024 105
TABLE 17 INDICATIVE PRICE OF DIGITAL HEALTH SOLUTIONS, BY REGION, 2024 106
TABLE 18 DIGITAL HEALTH MARKET: PORTER’S FIVE FORCES ANALYSIS 107
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 109
TABLE 20 KEY BUYING CRITERIA FOR DIGITAL HEALTH MARKET OFFERINGS 109
TABLE 21 UNMET NEEDS IN DIGITAL HEALTH MARKET 113
TABLE 22 END-USER EXPECTATIONS IN DIGITAL HEALTH MARKET 113
TABLE 23 DIGITAL HEALTH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 114
TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES 132
TABLE 25 DIGITAL HEALTH MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS 137
TABLE 26 DIGITAL HEALTH MARKET: RISK FACTORS AND MARKET ENTRY BARRIERS 139
TABLE 27 DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 142
TABLE 28 DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 29 DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 143
TABLE 30 DIGITAL HEALTH WEARABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 31 CONSUMER-GRADED WEARABLE HEALTHCARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 32 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 33 IMPLANTABLE DIGITAL HEALTH DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 34 HANDHELD & PORTABLE DIGITAL HEALTH DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 147
TABLE 35 STATIONARY DIGITAL HEALTH DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 148
TABLE 36 DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 149
TABLE 37 DIGITAL HEALTH SERVICES SOLUTIONS/APPLICATIONS MARKET,
BY REGION, 2023–2030 (USD MILLION) 149
TABLE 38 TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 39 COMPANIES OFFERING DIGITAL HEALTH SOLUTIONS FOR REMOTE PATIENT MONITORING 151
TABLE 40 REMOTE PATIENT MONITORING SOLUTIONS/APPLICATIONS MARKET,
BY REGION, 2023–2030 (USD MILLION) 151
TABLE 41 COMPANIES OFFERING DIGITAL HEALTH SOLUTIONS FOR VIRTUAL CARE 152
TABLE 42 VIRTUAL CARE & VIDEO CONSULTATION SOLUTIONS/APPLICATIONS MARKET,
BY REGION, 2023–2030 (USD MILLION) 152
TABLE 43 COMPANIES OFFERING VIRTUAL SITTING & NURSING PLATFORMS 153
TABLE 44 VIRTUAL SITTING & NURSING PLATFORMS MARKET, BY REGION,
2023–2030 (USD MILLION) 153
TABLE 45 MHEALTH APPS MARKET, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 46 DIGITAL THERAPEUTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 155
TABLE 47 DIGITAL PHARMACY & MEDICATION ACCESS SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 156
TABLE 48 DIGITAL DIAGNOSTICS & AT-HOME TESTING SOLUTIONS/APPLICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 157
TABLE 49 PATIENT PORTAL SOLUTIONS/APPLICATIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 50 OTHER DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 159
TABLE 51 DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 161
TABLE 52 COMPANIES OFFERING DIGITAL HEALTH FOR DIABETES SOLUTIONS 162
TABLE 53 DIGITAL HEALTH MARKET FOR DIABETES, BY REGION, 2023–2030 (USD MILLION) 162
TABLE 54 DIGITAL HEALTH MARKET FOR CARDIOLOGY, BY REGION,
2023–2030 (USD MILLION) 163
TABLE 55 DIGITAL HEALTH MARKET FOR MENTAL HEALTH & BEHAVIORAL HEALTH,
BY REGION, 2023–2030 (USD MILLION) 164
TABLE 56 COMPANIES OFFERING DIGITAL HEALTH SOLUTIONS FOR RESPIRATORY DISORDERS 165
TABLE 57 DIGITAL HEALTH MARKET FOR RESPIRATORY DISORDERS, BY REGION,
2023–2030 (USD MILLION) 165
TABLE 58 DIGITAL HEALTH MARKET FOR LIFESTYLE & WELLNESS IMPROVEMENT,
BY REGION, 2023–2030 (USD MILLION) 166
TABLE 59 DIGITAL HEALTH MARKET FOR NEUROLOGY, BY REGION,
2023–2030 (USD MILLION) 167
TABLE 60 DIGITAL HEALTH MARKET FOR MUSCULOSKELETAL DISORDERS/PAIN MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 168
TABLE 61 DIGITAL HEALTH MARKET FOR ONCOLOGY, BY REGION,
2023–2030 (USD MILLION) 169
TABLE 62 DIGITAL HEALTH MARKET FOR WOMEN’S HEALTH & REPRODUCTIVE HEALTH,
BY REGION, 2023–2030 (USD MILLION) 170
TABLE 63 DIGITAL HEALTH MARKET FOR OTHER DISEASES, BY REGION,
2023–2030 (USD MILLION) 170
TABLE 64 DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 172
TABLE 65 DIGITAL HEALTH MARKET FOR PREVENTIVE CARE & WELLNESS,
BY REGION, 2023–2030 (USD MILLION) 173
TABLE 66 DIGITAL HEALTH MARKET FOR DIAGNOSIS, BY REGION,
2023–2030 (USD MILLION) 174
TABLE 67 DIGITAL HEALTH MARKET FOR TREATMENT, BY REGION,
2023–2030 (USD MILLION) 175
TABLE 68 DIGITAL HEALTH MARKET FOR PATIENT MONITORING, BY REGION,
2023–2030 (USD MILLION) 176
TABLE 69 DIGITAL HEALTH MARKET FOR REHABILITATION & RECOVERY, BY REGION,
2023–2030 (USD MILLION) 177
TABLE 70 DIGITAL HEALTH MARKET FOR OTHER USE CASES, BY REGION,
2023–2030 (USD MILLION) 178
TABLE 71 DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 180
TABLE 72 DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 73 DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY REGION,
2023–2030 (USD MILLION) 181
TABLE 74 DIGITAL HEALTH MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 182
TABLE 75 DIGITAL HEALTH MARKET FOR CLINICS & OTHER OUTPATIENT SETTINGS,
BY REGION, 2023–2030 (USD MILLION) 183
TABLE 76 DIGITAL HEALTH MARKET FOR OTHER HEALTHCARE PROVIDERS,
BY REGION, 2023–2030 (USD MILLION) 184
TABLE 77 DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY REGION,
2023–2030 (USD MILLION) 185
TABLE 78 DIGITAL HEALTH MARKET FOR PUBLIC PAYERS, BY REGION,
2023–2030 (USD MILLION) 186
TABLE 79 DIGITAL HEALTH MARKET FOR PRIVATE PAYERS, BY REGION,
2023–2030 (USD MILLION) 187
TABLE 80 DIGITAL HEALTH MARKET FOR PATIENTS & CONSUMERS, BY REGION,
2023–2030 (USD MILLION) 188
TABLE 81 DIGITAL HEALTH MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY,
AND MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 189
TABLE 82 DIGITAL HEALTH MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 189
TABLE 83 DIGITAL HEALTH MARKET, BY REGION, 2023–2030 (USD MILLION) 191
TABLE 84 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 193
TABLE 85 NORTH AMERICA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 194
TABLE 86 NORTH AMERICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 87 NORTH AMERICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 88 NORTH AMERICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 89 NORTH AMERICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 90 NORTH AMERICA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 196
TABLE 91 NORTH AMERICA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 196
TABLE 92 NORTH AMERICA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 197
TABLE 93 NORTH AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 94 NORTH AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 95 US: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 198
TABLE 96 US: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 97 US: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 98 US: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 99 US: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 100 US: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 202
TABLE 101 US: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 202
TABLE 102 US: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 203
TABLE 103 US: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 104 US: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 105 CANADA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 205
TABLE 106 CANADA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 107 CANADA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 108 CANADA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 109 CANADA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS
MARKET, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 110 CANADA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 207
TABLE 111 CANADA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 207
TABLE 112 CANADA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 208
TABLE 113 CANADA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 114 CANADA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 115 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210
TABLE 116 EUROPE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 210
TABLE 117 EUROPE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 118 EUROPE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 119 EUROPE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 120 EUROPE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 121 EUROPE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 212
TABLE 122 EUROPE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 213
TABLE 123 EUROPE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 213
TABLE 124 EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 125 EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 126 GERMANY: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 215
TABLE 127 GERMANY: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 128 GERMANY: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 129 GERMANY: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 130 GERMANY: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 131 GERMANY: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 217
TABLE 132 GERMANY: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 218
TABLE 133 GERMANY: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 218
TABLE 134 GERMANY: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 135 GERMANY: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 136 UK: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 220
TABLE 137 UK: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 138 UK: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 139 UK: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 140 UK: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 141 UK: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 222
TABLE 142 UK: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 222
TABLE 143 UK: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 223
TABLE 144 UK: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 145 UK: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 146 FRANCE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 224
TABLE 147 FRANCE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 148 FRANCE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 149 FRANCE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 150 FRANCE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 151 FRANCE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 227
TABLE 152 FRANCE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 227
TABLE 153 FRANCE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 228
TABLE 154 FRANCE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 155 FRANCE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 156 ITALY: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 230
TABLE 157 ITALY: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 158 ITALY: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 230
TABLE 159 ITALY: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 231
TABLE 160 ITALY: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 161 ITALY: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 232
TABLE 162 ITALY: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 232
TABLE 163 ITALY: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 233
TABLE 164 ITALY: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 165 ITALY: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 166 SPAIN: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 235
TABLE 167 SPAIN: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 168 SPAIN: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 169 SPAIN: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 170 SPAIN: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 171 SPAIN: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 237
TABLE 172 SPAIN: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 237
TABLE 173 SPAIN: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 238
TABLE 174 SPAIN: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 175 SPAIN: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 176 REST OF EUROPE: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 239
TABLE 177 REST OF EUROPE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 178 REST OF EUROPE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 179 REST OF EUROPE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 180 REST OF EUROPE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 181 REST OF EUROPE: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 242
TABLE 182 REST OF EUROPE: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 242
TABLE 183 REST OF EUROPE: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 243
TABLE 184 REST OF EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 185 REST OF EUROPE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 186 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246
TABLE 187 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 247
TABLE 188 ASIA PACIFIC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 189 ASIA PACIFIC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 190 ASIA PACIFIC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 191 ASIA PACIFIC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 192 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 249
TABLE 193 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 249
TABLE 194 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 250
TABLE 195 ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 196 ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 197 CHINA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 251
TABLE 198 CHINA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 199 CHINA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 200 CHINA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 201 CHINA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 202 CHINA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 254
TABLE 203 CHINA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 254
TABLE 204 CHINA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 255
TABLE 205 CHINA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 206 CHINA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 207 JAPAN: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 257
TABLE 208 JAPAN: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 209 JAPAN: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 210 JAPAN: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 258
TABLE 211 JAPAN: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 212 JAPAN: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 259
TABLE 213 JAPAN: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 259
TABLE 214 JAPAN: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 260
TABLE 215 JAPAN: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 216 JAPAN: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 217 INDIA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 262
TABLE 218 INDIA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 219 INDIA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 220 INDIA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 263
TABLE 221 INDIA: TELEHEALTHCARE/ TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 222 INDIA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 264
TABLE 223 INDIA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 264
TABLE 224 INDIA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 265
TABLE 225 INDIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 265
TABLE 226 INDIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023–2030 (USD MILLION) 265
TABLE 227 AUSTRALIA: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 266
TABLE 228 AUSTRALIA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 229 AUSTRALIA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 230 AUSTRALIA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 231 AUSTRALIA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 232 AUSTRALIA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 269
TABLE 233 AUSTRALIA: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 269
TABLE 234 AUSTRALIA: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 270
TABLE 235 AUSTRALIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 236 AUSTRALIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 237 SOUTH KOREA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 271
TABLE 238 SOUTH KOREA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 272
TABLE 239 SOUTH KOREA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 272
TABLE 240 SOUTH KOREA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 241 SOUTH KOREA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 242 SOUTH KOREA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 274
TABLE 243 SOUTH KOREA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 274
TABLE 244 SOUTH KOREA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 275
TABLE 245 SOUTH KOREA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 246 SOUTH KOREA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 247 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 276
TABLE 248 REST OF ASIA PACIFIC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 249 REST OF ASIA PACIFIC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 250 REST OF ASIA PACIFIC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 251 REST OF ASIA PACIFIC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 252 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 279
TABLE 253 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 279
TABLE 254 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 280
TABLE 255 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 256 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 257 LATIN AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 282
TABLE 258 LATIN AMERICA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 282
TABLE 259 LATIN AMERICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 260 LATIN AMERICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 283
TABLE 261 LATIN AMERICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 262 LATIN AMERICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 263 LATIN AMERICA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 284
TABLE 264 LATIN AMERICA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 285
TABLE 265 LATIN AMERICA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 285
TABLE 266 LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 267 LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 268 BRAZIL: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 287
TABLE 269 BRAZIL: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 270 BRAZIL: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 271 BRAZIL: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 272 BRAZIL: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289
TABLE 273 BRAZIL: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 289
TABLE 274 BRAZIL: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 290
TABLE 275 BRAZIL: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 290
TABLE 276 BRAZIL: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 290
TABLE 277 BRAZIL: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023–2030 (USD MILLION) 291
TABLE 278 MEXICO: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 292
TABLE 279 MEXICO: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 292
TABLE 280 MEXICO: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 293
TABLE 281 MEXICO: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 282 MEXICO: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 283 MEXICO: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 294
TABLE 284 MEXICO: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 295
TABLE 285 MEXICO: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 295
TABLE 286 MEXICO: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 296
TABLE 287 MEXICO: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 288 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 297
TABLE 289 REST OF LATIN AMERICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 297
TABLE 290 REST OF LATIN AMERICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 298
TABLE 291 REST OF LATIN AMERICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 298
TABLE 292 REST OF LATIN AMERICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 293 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 299
TABLE 294 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 300
TABLE 295 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 300
TABLE 296 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 297 REST OF LATIN AMERICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 298 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 302
TABLE 299 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 303
TABLE 300 MIDDLE EAST & AFRICA: DIGITAL HEALTH HARDWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 303
TABLE 301 MIDDLE EAST & AFRICA: DIGITAL HEALTH WEARABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 303
TABLE 302 MIDDLE EAST & AFRICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 304
TABLE 303 MIDDLE EAST & AFRICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 304
TABLE 304 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 305
TABLE 305 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 305
TABLE 306 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 306
TABLE 307 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 308 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 309 GCC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 307
TABLE 310 GCC: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 308
TABLE 311 GCC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 308
TABLE 312 GCC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308
TABLE 313 GCC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 309
TABLE 314 GCC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 309
TABLE 315 GCC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 310
TABLE 316 GCC: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 310
TABLE 317 GCC: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 311
TABLE 318 GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 311
TABLE 319 GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 311
TABLE 320 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 312
TABLE 321 SAUDI ARABIA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 313
TABLE 322 SAUDI ARABIA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 313
TABLE 323 SAUDI ARABIA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 314
TABLE 324 SAUDI ARABIA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314
TABLE 325 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 315
TABLE 326 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 315
TABLE 327 SAUDI ARABIA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 316
TABLE 328 SAUDI ARABIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 316
TABLE 329 SAUDI ARABIA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 316
TABLE 330 UAE: DIGITAL HEALTH MARKET, BY OFFERING, 2023–2030 (USD MILLION) 318
TABLE 331 UAE: DIGITAL HEALTH HARDWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 332 UAE: DIGITAL HEALTH WEARABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 333 UAE: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE,
2023–2030 (USD MILLION) 319
TABLE 334 UAE: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 319
TABLE 335 UAE: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 320
TABLE 336 UAE: DIGITAL HEALTH MARKET, BY USE CASE, 2023–2030 (USD MILLION) 320
TABLE 337 UAE: DIGITAL HEALTH MARKET, BY END USER, 2023–2030 (USD MILLION) 321
TABLE 338 UAE: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023–2030 (USD MILLION) 321
TABLE 339 UAE: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 321
TABLE 340 REST OF GCC: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 322
TABLE 341 REST OF GCC: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 323
TABLE 342 REST OF GCC: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 323
TABLE 343 REST OF GCC: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 324
TABLE 344 REST OF GCC: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324
TABLE 345 REST OF GCC: DIGITAL HEALTH MARKET, BY DISEASE, 2023–2030 (USD MILLION) 325
TABLE 346 REST OF GCC: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 325
TABLE 347 REST OF GCC: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 326
TABLE 348 REST OF GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 326
TABLE 349 REST OF GCC: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 326
TABLE 350 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 327
TABLE 351 SOUTH AFRICA: DIGITAL HEALTH HARDWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 328
TABLE 352 SOUTH AFRICA: DIGITAL HEALTH WEARABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 328
TABLE 353 SOUTH AFRICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 354 SOUTH AFRICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 355 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 330
TABLE 356 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 330
TABLE 357 SOUTH AFRICA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 331
TABLE 358 SOUTH AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 331
TABLE 359 SOUTH AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023–2030 (USD MILLION) 331
TABLE 360 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY OFFERING,
2023–2030 (USD MILLION) 332
TABLE 361 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH HARDWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 333
TABLE 362 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH WEARABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 333
TABLE 363 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334
TABLE 364 REST OF MIDDLE EAST & AFRICA: TELEHEALTHCARE/TELEMEDICINE SOLUTIONS/APPLICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334
TABLE 365 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY DISEASE,
2023–2030 (USD MILLION) 335
TABLE 366 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY USE CASE,
2023–2030 (USD MILLION) 335
TABLE 367 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY END USER,
2023–2030 (USD MILLION) 336
TABLE 368 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 336
TABLE 369 REST OF MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 336
TABLE 370 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL HEALTH MARKET, JANUARY 2022–JULY 2025 337
TABLE 371 DIGITAL HEALTH MARKET: DEGREE OF COMPETITION 341
TABLE 372 DIGITAL HEALTH MARKET: REGION FOOTPRINT 348
TABLE 373 DIGITAL HEALTH MARKET: OFFERING FOOTPRINT 349
TABLE 374 DIGITAL HEALTH MARKET: DISEASE FOOTPRINT 350
TABLE 375 DIGITAL HEALTH MARKET: USE CASE FOOTPRINT 351
TABLE 376 DIGITAL HEALTH MARKET: END USER FOOTPRINT 352
TABLE 1 DIGITAL HEALTH MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 355
TABLE 377 DIGITAL HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 355
TABLE 378 DIGITAL HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY DISEASE 356
TABLE 379 DIGITAL HEALTH MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 356
TABLE 380 DIGITAL HEALTH MARKET: DEALS, JANUARY 2022–JULY 2025 357
TABLE 381 DIGITAL HEALTH MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 358
TABLE 382 MEDTRONIC: COMPANY OVERVIEW 359
TABLE 383 MEDTRONIC: PRODUCTS OFFERED 360
TABLE 384 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 362
TABLE 385 MEDTRONIC: DEALS, JANUARY 2022–JULY 2025 363
TABLE 386 MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 364
TABLE 387 ABBOTT: COMPANY OVERVIEW 366
TABLE 388 ABBOTT: PRODUCTS OFFERED 367
TABLE 389 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 368
TABLE 390 ABBOTT: DEALS, JANUARY 2022–JULY 2025 369
TABLE 391 DEXCOM, INC.: COMPANY OVERVIEW 371
TABLE 392 DEXCOM, INC.: PRODUCTS OFFERED 372
TABLE 393 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 372
TABLE 394 DEXCOM, INC.: DEALS, JANUARY 2022–JULY 2025 373
TABLE 395 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 375
TABLE 396 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 376
TABLE 397 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 378
TABLE 398 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JULY 2025 378
TABLE 399 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JULY 2025 379
TABLE 400 FITBIT, INC.: COMPANY OVERVIEW 380
TABLE 401 FITBIT, INC.: PRODUCTS OFFERED 381
TABLE 402 FITBIT, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 382
TABLE 403 FITBIT, INC.: DEALS, JANUARY 2022–JULY 2025 382
TABLE 404 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW 384
TABLE 405 OMRON HEALTHCARE, INC.: PRODUCTS OFFERED 385
TABLE 406 OMRON HEALTHCARE, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 387
TABLE 407 OMRON HEALTHCARE, INC., JANUARY 2022–JULY 2025 387
TABLE 408 APPLE, INC.: COMPANY OVERVIEW 389
TABLE 409 APPLE, INC.: PRODUCTS OFFERED 390
TABLE 410 APPLE, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 391
TABLE 411 APPLE, INC.: DEALS, JANUARY 2022–JULY 2025 392
TABLE 412 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 393
TABLE 413 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 394
TABLE 414 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 395
TABLE 415 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025 396
TABLE 416 MASIMO: COMPANY OVERVIEW 397
TABLE 417 MASIMO: PRODUCTS OFFERED 398
TABLE 418 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 399
TABLE 419 MASIMO: DEALS, JANUARY 2022–JULY 2025 400
TABLE 420 TELADOC HEALTH, INC.: COMPANY OVERVIEW 401
TABLE 421 TELADOC HEALTH, INC.: PRODUCTS OFFERED 402
TABLE 422 TELADOC HEALTH, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 403
TABLE 423 TELADOC HEALTH, INC.: DEALS, JANUARY 2022–JULY 2025 404
TABLE 424 AMERICAN WELL: COMPANY OVERVIEW 406
TABLE 425 AMERICAN WELL: PRODUCTS OFFERED 407
TABLE 426 AMERICAN WELL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 408
TABLE 427 AMERICAN WELL: DEALS, JANUARY 2022–JULY 2025 408
TABLE 428 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 409
TABLE 429 HIMS & HERS HEALTH, INC.: COMPANY OVERVIEW 410
TABLE 430 HIMS & HERS HEALTH, INC.: PRODUCTS OFFERED 411
TABLE 431 HIMS & HERS HEALTH, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 412
TABLE 432 HIMS & HERS HEALTH, INC.: DEALS, JANUARY 2022–JULY 2025 413
TABLE 433 HEADSPACE: COMPANY OVERVIEW 414
TABLE 434 HEADSPACE: PRODUCTS OFFERED 414
TABLE 435 HEADSPACE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 415
TABLE 436 HEADSPACE: DEALS, JANUARY 2022–JULY 2025 416
TABLE 437 NOOM, INC.: COMPANY OVERVIEW 417
TABLE 438 NOOM, INC.: PRODUCTS OFFERED 417
TABLE 439 NOOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 418
TABLE 440 NOOM, INC.: DEALS, JANUARY 2022–JULY 2025 418
TABLE 441 CEREBRAL INC.: COMPANY OVERVIEW 420
TABLE 442 CEREBRAL INC.: PRODUCTS OFFERED 420
TABLE 443 CEREBRAL INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 421
TABLE 444 CEREBRAL INC.: DEALS, JANUARY 2022–JULY 2025 421
TABLE 445 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 423
TABLE 446 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 423
TABLE 447 EPIC SYSTEM CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 424
TABLE 448 EPIC SYSTEM CORPORATION: DEALS, JANUARY 2022–JULY 2025 424
TABLE 449 OMADA HEALTH INC.: COMPANY OVERVIEW 425
TABLE 450 OMADA HEALTH INC.: PRODUCTS OFFERED 426
TABLE 451 OMADA HEALTH INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 427
TABLE 452 OMADA HEALTH INC.: DEALS, JANUARY 2022–JULY 2025 428
TABLE 453 ORACLE: COMPANY OVERVIEW 429
TABLE 454 ORACLE: PRODUCTS OFFERED 430
TABLE 455 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 431
TABLE 456 ORACLE: DEALS, JANUARY 2022–JULY 2025 431
TABLE 457 CLICK THERAPEUTICS, INC.: COMPANY OVERVIEW 432
TABLE 458 CLICK THERAPEUTICS, INC.: PRODUCTS OFFERED 432
TABLE 459 CLICK THERAPEUTICS, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 433
TABLE 460 CLICK THERAPEUTICS, INC.: DEALS, JANUARY 2022–JULY 2025 434
TABLE 461 WELLDOC, INC.: COMPANY OVERVIEW 435
TABLE 462 WELLDOC, INC.: PRODUCTS OFFERED 435
TABLE 463 WELLDOC, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 436
TABLE 464 WELLDOC, INC.: DEALS, JANUARY 2022–JULY 2025 436
TABLE 465 EVERLYWELL: COMPANY OVERVIEW 437
TABLE 466 EVERLYWELL: PRODUCTS OFFERED 437
TABLE 467 EVERLYWELL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 438
TABLE 468 EVERLYWELL: DEALS, JANUARY 2022–JULY 2025 439
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 43
FIGURE 2 PRIMARY SOURCES 46
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 48
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 49
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION 50
FIGURE 6 DIGITAL HEALTH MARKET: REVENUE ESTIMATION APPROACH 51
FIGURE 7 BOTTOM-UP APPROACH: END USER SPENDING ON DIGITAL HEALTH 53
FIGURE 8 TOP-DOWN APPROACH 54
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 56
FIGURE 10 DIGITAL HEALTH MARKET: CAGR PROJECTIONS 57
FIGURE 11 DATA TRIANGULATION METHODOLOGY 58
FIGURE 12 DIGITAL HEALTH MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 61
FIGURE 13 DIGITAL HEALTH MARKET, BY DISEASE, 2025 VS. 2030 (USD MILLION) 62
FIGURE 14 DIGITAL HEALTH MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 63
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF DIGITAL HEALTH MARKET 64
FIGURE 16 RISING FOCUS ON PATIENT-CENTRIC HEALTHCARE SOLUTIONS TO DRIVE MARKET 66
FIGURE 17 HEALTHCARE PROVIDERS HELD LARGEST SHARE OF NORTH AMERICAN
MARKET IN 2024 67
FIGURE 18 MARKET IN INDIA TO REGISTER HIGHEST GROWTH 68
FIGURE 19 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 69
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH BETWEEN 2025 & 2030 69
FIGURE 21 DIGITAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 70
FIGURE 22 SMARTPHONE USERS WORLDWIDE, 2016–2027 (BILLION) 71
FIGURE 23 GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION) 72
FIGURE 24 DIGITAL HEALTH MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80
FIGURE 25 DIGITAL HEALTH MARKET: ECOSYSTEM ANALYSIS 83
FIGURE 26 DIGITAL HEALTH MARKET: SUPPLY CHAIN ANALYSIS (2024) 84
FIGURE 27 DIGITAL HEALTH MARKET: PORTER’S FIVE FORCES ANALYSIS 106
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 108
FIGURE 29 KEY BUYING CRITERIA FOR DIGITAL HEALTH OFFERINGS 109
FIGURE 30 PATENT PUBLICATION TRENDS IN DIGITAL HEALTH MARKET, 2015–2025 110
FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “DIGITAL HEALTH” PATENTS (JANUARY 2015–MARCH 2025) 111
FIGURE 32 MAJOR PATENTS IN DIGITAL HEALTH MARKET (JANUARY 2015–MARCH 2025) 112
FIGURE 33 INVESTMENT LANDSCAPE AND FUNDING SCENARIO, 2025 (USD MILLION) 117
FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE 8518, BY COUNTRY,
2024 (USD THOUSAND) 118
FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE 8518, BY COUNTRY,
2024 (USD THOUSAND) 118
FIGURE 36 IMPORTS OF PRODUCTS UNDER HSN CODE 9021, BY COUNTRY,
2024 (USD THOUSAND) 119
FIGURE 37 EXPORTS OF PRODUCTS UNDER HSN CODE 9021, BY COUNTRY,
2024 (USD THOUSAND) 119
FIGURE 38 IMPORTS OF PRODUCTS UNDER HSN CODE 9022, BY COUNTRY,
2024 (USD THOUSAND) 120
FIGURE 39 EXPORTS OF PRODUCTS UNDER HSN CODE 9022, BY COUNTRY,
2024 (USD THOUSAND) 120
FIGURE 40 IMPORTS OF PRODUCTS UNDER HSN CODE 9018, BY COUNTRY,
2024 (USD THOUSAND) 121
FIGURE 41 EXPORTS OF PRODUCTS UNDER HSN CODE 9018, BY COUNTRY,
2024 (USD THOUSAND) 121
FIGURE 42 MARKET POTENTIAL OF AI/GENERATIVE AI DIGITAL HEALTH ACROSS INDUSTRIES 124
FIGURE 43 NORTH AMERICA: DIGITAL HEALTH MARKET SNAPSHOT 193
FIGURE 44 ASIA PACIFIC: DIGITAL HEALTH MARKET SNAPSHOT 246
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL HEALTH MARKET,
2020–2024 (USD MILLION) 340
FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL HEALTH MARKET (2024) 341
FIGURE 47 DIGITAL HEALTH MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 343
FIGURE 48 EV/EBITDA OF KEY VENDORS, 2025 344
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 345
FIGURE 50 DIGITAL HEALTH MARKET: COMPANY EVALUATION MATRIX, 2024 346
FIGURE 51 DIGITAL HEALTH MARKET: COMPANY FOOTPRINT 347
FIGURE 52 DIGITAL HEALTH MARKET: STARTUP/SME EVALUATION MATRIX, 2024 354
FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT (2025) 360
FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2024) 367
FIGURE 55 DEXCOM, INC.: COMPANY SNAPSHOT (2024) 371
FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 376
FIGURE 57 GOOGLE: COMPANY SNAPSHOT (2024) 381
FIGURE 58 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT (2023) 385
FIGURE 59 APPLE, INC.: COMPANY SNAPSHOT (2024) 390
FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 394
FIGURE 61 MASIMO: COMPANY SNAPSHOT (2024) 398
FIGURE 62 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2024) 402
FIGURE 63 AMERICAN WELL: COMPANY SNAPSHOT (2024) 407
FIGURE 64 HIMS & HERS HEALTH, INC.: COMPANY SNAPSHOT (2024) 411
FIGURE 65 OMADA HEALTH INC.: COMPANY SNAPSHOT (2024) 426
FIGURE 66 ORACLE: COMPANY SNAPSHOT (2025) 430
